These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30666931)

  • 1. Zika Virus IgM Detection and Neutralizing Antibody Profiles 12-19 Months after Illness Onset.
    Griffin I; Martin SW; Fischer M; Chambers TV; Kosoy O; Falise A; Ponomareva O; Gillis LD; Blackmore C; Jean R
    Emerg Infect Dis; 2019 Feb; 25(2):299-303. PubMed ID: 30666931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zika Virus IgM 25 Months after Symptom Onset, Miami-Dade County, Florida, USA.
    Griffin I; Martin SW; Fischer M; Chambers TV; Kosoy OL; Goldberg C; Falise A; Villamil V; Ponomareva O; Gillis LD; Blackmore C; Jean R
    Emerg Infect Dis; 2019 Dec; 25(12):2264-2265. PubMed ID: 31742511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survey on neutralizing antibodies against Zika virus eighteen months post-outbreak in two southern Thailand communities.
    Densathaporn T; Sangthong R; Sakolnapa M; Surasombatpattana S; Kemapunmanus M; Masrinoul P; Yoksan S; McNeil EB; Chongsuvivatwong V
    BMC Infect Dis; 2020 Dec; 20(1):921. PubMed ID: 33272192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Zika virus neutralizing antibodies in healthy adults in Vietnam during and after the Zika virus epidemic season: a longitudinal population-based survey.
    Nguyen CT; Moi ML; Le TQM; Nguyen TTT; Vu TBH; Nguyen HT; Pham TTH; Le THT; Nguyen LMH; Phu Ly MH; Ng CFS; Takemura T; Morita K; Hasebe F
    BMC Infect Dis; 2020 May; 20(1):332. PubMed ID: 32393198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of a Zika Virus (ZIKV) Immunoglobulin M-Specific Diagnostic Assay Are Highly Correlated With Detection of Neutralizing Anti-ZIKV Antibodies in Neonates With Congenital Disease.
    Cordeiro MT; Brito CA; Pena LJ; Castanha PM; Gil LH; Lopes KG; Dhalia R; Meneses JA; Ishigami AC; Mello LM; Alencar LX; Guarines KM; Rodrigues LC; Marques ET
    J Infect Dis; 2016 Dec; 214(12):1897-1904. PubMed ID: 27923950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection.
    Collins MH; McGowan E; Jadi R; Young E; Lopez CA; Baric RS; Lazear HM; de Silva AM
    Emerg Infect Dis; 2017 May; 23(5):773-781. PubMed ID: 28418292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-Reaction, Enhancement, and Neutralization Activity of Dengue Virus Antibodies against Zika Virus: A Study in the Mexican Population.
    Montecillo-Aguado MR; Montes-Gómez AE; García-Cordero J; Corzo-Gómez J; Vivanco-Cid H; Mellado-Sánchez G; Muñoz-Medina JE; Gutiérrez-Castañeda B; Santos-Argumedo L; González-Bonilla C; Cedillo-Barrón L
    J Immunol Res; 2019; 2019():7239347. PubMed ID: 31565661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of IgG Depletion in a Neutralization Assay Facilitates Differential Diagnosis of Zika and Dengue in Secondary Flavivirus Infection Cases.
    Calvert AE; Boroughs KL; Laven J; Stovall JL; Luy BE; Kosoy OI; Huang CY
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29618505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.
    Khandia R; Munjal A; Dhama K; Karthik K; Tiwari R; Malik YS; Singh RK; Chaicumpa W
    Front Immunol; 2018; 9():597. PubMed ID: 29740424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perinatal analyses of Zika- and dengue virus-specific neutralizing antibodies: A microcephaly case-control study in an area of high dengue endemicity in Brazil.
    Castanha PMS; Souza WV; Braga C; Araújo TVB; Ximenes RAA; Albuquerque MFPM; Montarroyos UR; Miranda-Filho DB; Cordeiro MT; Dhalia R; Marques ETA; Rodrigues LC; Martelli CMT;
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007246. PubMed ID: 30856223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zika Virus Antibody Titers Three Years after Confirmed Infection.
    Langerak T; Kasbergen LMR; Chandler F; Brinkman T; Faerber Z; Phalai K; Ulbert S; Rockstroh A; Bruin E; Koopmans MPG; Rockx B; van Gorp ECM; Vreden S
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serodiagnosis of Zika virus (ZIKV) infections by a novel NS1-based ELISA devoid of cross-reactivity with dengue virus antibodies: a multicohort study of assay performance, 2015 to 2016.
    Steinhagen K; Probst C; Radzimski C; Schmidt-Chanasit J; Emmerich P; van Esbroeck M; Schinkel J; Grobusch MP; Goorhuis A; Warnecke JM; Lattwein E; Komorowski L; Deerberg A; Saschenbrecker S; Stöcker W; Schlumberger W
    Euro Surveill; 2016 Dec; 21(50):. PubMed ID: 28006649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of Zika and Dengue Virus Antibodies among Migrant Workers, Taiwan, 2017.
    Perng GC; Ho TC; Shih HI; Lee CH; Huang PW; Chung CH; Ko NY; Ko WC; Chien YW
    Emerg Infect Dis; 2019 Apr; 25(4):814-816. PubMed ID: 30882327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontogeny of the B- and T-cell response in a primary Zika virus infection of a dengue-naïve individual during the 2016 outbreak in Miami, FL.
    Ricciardi MJ; Magnani DM; Grifoni A; Kwon YC; Gutman MJ; Grubaugh ND; Gangavarapu K; Sharkey M; Silveira CGT; Bailey VK; Pedreño-Lopez N; Gonzalez-Nieto L; Maxwell HS; Domingues A; Martins MA; Pham J; Weiskopf D; Altman J; Kallas EG; Andersen KG; Stevenson M; Lichtenberger P; Choe H; Whitehead SS; Sette A; Watkins DI
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006000. PubMed ID: 29267278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Serologic Cross-Reactivity Between Dengue Virus and SARS-CoV-2 in Patients with Acute Febrile Illness - United States and Puerto Rico, April 2020-March 2021.
    Munoz-Jordan J; Cardona J; Beltrán M; Colón C; Schiffer J; Stewart-Clark E; Zellner B; Semenova V; Li Y; Jia LT; Maniatis P; Pawloski L; Adams L; Paz-Bailey G; Rivera-Amill V; Medina F
    MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(10):375-377. PubMed ID: 35271558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-evaluation of routine dengue virus serology in travelers in the era of Zika virus emergence.
    van Meer MPA; Mögling R; Klaasse J; Chandler FD; Pas SD; van der Eijk AA; Koopmans MPG; Reusken CBEM; GeurtsvanKessel CH
    J Clin Virol; 2017 Jul; 92():25-31. PubMed ID: 28505571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serologic Testing for Zika Virus: Comparison of Three Zika Virus IgM-Screening Enzyme-Linked Immunosorbent Assays and Initial Laboratory Experiences.
    Granger D; Hilgart H; Misner L; Christensen J; Bistodeau S; Palm J; Strain AK; Konstantinovski M; Liu D; Tran A; Theel ES
    J Clin Microbiol; 2017 Jul; 55(7):2127-2136. PubMed ID: 28446573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a Rapid Immunochromatographic Assay and Two Enzyme-Linked Immunosorbent Assays for Detection of IgM-Class Antibodies to Zika Virus.
    Granger D; Theel ES
    J Clin Microbiol; 2019 Mar; 57(3):. PubMed ID: 30541936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of 2 Commercial Serologic Tests for Diagnosing Zika Virus Infection.
    Matheus S; Talla C; Labeau B; de Laval F; Briolant S; Berthelot L; Vray M; Rousset D
    Emerg Infect Dis; 2019 Jun; 25(6):1153-1160. PubMed ID: 31107211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different Cross-Reactivities of IgM Responses in Dengue, Zika and Tick-Borne Encephalitis Virus Infections.
    Stiasny K; Malafa S; Aberle SW; Medits I; Tsouchnikas G; Aberle JH; Holzmann H; Heinz FX
    Viruses; 2021 Mar; 13(4):. PubMed ID: 33807442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.